Two monoclonal antibodies, anti-IL8Rl and anti-IL8R2, raised against both interleukin 8 receptors (IL-8R) of human neutrophils, IL-8R1 and IL-8R2, were used to study individual receptor functions after stimulation with IL-8, GROa, or NAP-2. Efficacy and selectivity of the antibodies were tested in Jurkat cells transfected with cDNA coding for one or the other receptor. The binding of 1251-labeled IL-8 and IL-8-induced changes of the cytosolic free Ca2+ concentration were inhibited by anti-IL8Rl in cells expressing IL-8R1 and by anti-IL8R2 in cells expressing IL-8R2. In human neutrophils, release of elastase was observed after stimulation with IL-8 or GROa. The response to IL-8 was inhibited slightly by anti-IL8R1 and more substantially when both monoclonal antibodies were present, while the response to GROa was inhibited by anti-IL8R2 but was not affected by anti-IL8Rl. These results indicate that both IL-8 receptors can signal independently for granule enzyme release. Superoxide production, a measure of the respiratory burst, was obtained with increasing concentrations of IL-8 with maximum effects at 25 to 50 nM, but no response was observed upon challenge with GROca or NAP-2 up to 1000 nM. The superoxide production induced by IL-8 was inhibited by anti-IL8Rl, but was not affected by anti-IL8R2. Stimulation of neutrophils with IL-8, in contrast to GROa or NAP-2, also elicited phospholipase D activity. The effect of IL-8 was again inhibited by anti-IL8Rl but not by anti-IL8R2, indicating that this response, like the respiratory burst, was mediated by IL-8R1. Taken together, our results show that IL-8R1 and IL-8R2 are functionally different. Responses, such as cytosolic free Ca2+ changes and the release of granule enzymes, are mediated through both receptors, whereas the respiratory burst and the activation of phospholipase D depend exclusively on stimulation through IL-SRi.
Chemokines constitute a large family of structurally related proteins which activate and attract leukocytes. Interleukin 8 (IL-8) and its analogs, GROa, GRO,3, GROT, NAP-2, and ENA-78, act predominantly on neutrophils and are called CXC chemokines because their first two conserved cysteines are separated by one amino acid (1) . CXC chemokines share two distinct receptors, IL-8 receptors 1 (IL-8R1) and IL-8 receptor 2 (IL-8R2), which are both expressed in high numbers on neutrophils (1) . IL-8 binds with high affinity (Kd values between 0.5 to 3 nM) to both receptors, whereas all the other CXC chemokines have high affinity for IL-8R2 only (2, 3) . The two receptors have considerable amino acid sequence identity within the seven transmembrane domains and connecting loops, but differ almost totally in their NH2-and COOHterminal regions. This suggests that they not only possess distinct ligand-binding properties but also signal differently. Because the receptors are expressed together on neutrophils, their individual properties were studied in Jurkat cells after transfection of the respective cDNA. IL-8R1 and IL-8R2 were found to function independently and to be equivalent in mediating changes of cytosolic free Ca2+ (4), activation of mitogen-activating protein kinase (5) and chemotaxis (4) in response to IL-8. We have now generated monoclonal antibodies that selectively interact with IL-8R1 or IL-8R2 to assess the function of the single receptors in the neutrophils. In this paper we show that activation of phospholipase D (PLD) and superoxide production via the NADPH oxidase is triggered by IL-8R1 but not by IL-8R2, whereas the release of granule enzymes and the changes of cytosolic free Ca2+ are mediated by both receptors.
MATERIALS AND METHODS Materials. RPMI 1640 medium and other cell culture supplements, including G-418 (Geneticin), were obtained from GIBCO/BRL. The chemokines IL-8, GROa, and NAP-2 were chemically synthesized (6) and generously provided by Ian Clark-Lewis (Adelaide, Australia). 125I-Labeled Nal was obtained from Amersham and [9,10-3H]oleic acid was from DuPont/New England Nuclear. All other reagents were purchased at the highest degree of purity from Merck, Fluka, or Sigma. Phosphatidylethanol was prepared as described (7) .
Monoclonal Antibodies. Monoclonal antibodies against the IL-8 receptors, anti-IL8R1 (LS-33-5A12.5, IgG2b isotype) and anti-IL8R2 (LS-37-6C6.1, IgGl isotype), were produced by immunizing mice with mouse pre-B lymphoma L1-2 cells (a kind gift of J. J. Campbell and E. C. Butcher, Palo Alto, CA) that were transfected with IL-8R1 or IL-8R2 cDNA. The antibodies were identified by flow cytometry, and hybridomas were subcloned by limiting dilution.
Cells. Stable Jurkat cell transfectants bearing functional IL-8R1 or IL-8R2 were generated as described (4) and maintained at 37°C in 5% CO2 in RPMI 1640 medium containing 10% fetal calf serum, 2 mM L-glutamine, 100 units of penicillin per ml, 100 jig of streptomycin per ml, and 0.8 mg of G-418 per ml. Human neutrophils were isolated from buffy coats of donor blood (8) .
Binding Assays. IL-8 was iodinated by using 2 mCi (74 mBq) Na-1251 as described (2 at 37°C with 5 jig of cytochalasin B per ml, and finally stimulated (5 x 106 cells in 1 ml) with IL-8, GROa, or NAP-2. After 10 min, 3 ml of chloroform/methanol (1:2) was added, and the monophase split by addition of 0.75 ml chloroform and 0.75 ml water. The lower phase containing the phospholipids was recovered, supplemented with carrier phosphatidylethanol, and dried by speedvac centrifugation. The lipids were separated by thin-layer chromatography on silica gel 60 with chloroform/methanol/acetic acid (65:15:5) and stained with iodine vapor, and the phosphatidylethanol spots were quantified by liquid scintillation counting.
RESULTS
The monoclonal receptor antibodies anti-IL8R1 and anti-IL8R2 were first tested on Jurkat cells transfected with receptor cDNA and expressing either IL-8R1 or IL-8R2 and were subsequently used to investigate the responses of human neutrophils stimulated with IL-8, GROa, or NAP-2. The transfected receptors had similar affinities for IL-8 (Kd values of 8.0 ± 2.5 and 6.0 ± 3.0 nM for IL-8R1 and IL-8R2, respectively) and were expressed in similar numbers (13,000 ± 4000 IL-8R1 and 14,500 + 9500 IL-8R2 per Jurkat cell). In the present study, the chemokines were mainly used at concentrations between 10 and 100 nM. Under these conditions, GROa and NAP-2 act exclusively through IL-8R2 (3). The antibodies were not stimulatory, and no responses of Jurkat cells or neutrophils were observed on addition of anti-IL8R1 or anti-IL8R2 alone or in combination.
Effects on Jurkat Transfectants. Cells expressing one or the other IL-8 receptors were exposed to increasing concentrations of the monoclonal antibodies and the binding of 1251- (Fig. lb) (11) , and the GRO proteins (12) . The effect of the receptor antibodies on the release of elastase is illustrated in Fig. 2 . The response to IL-8 was slightly inhibited by anti-IL8R1 but was not affected by anti-IL8R2. The release induced by GROa, on the other hand, was markedly inhibited by anti-IL8R2 and was not affected by anti-IL8R1. As expected, the IL-8 response was markedly inhibited when-the neutrophils were pretreated with both antibodies together. These experiments indicate that both CXC chemokine receptors signal for enzyme release. The slight inhibition of the effect of IL-8 by anti-IL8R1, as opposed to anti-IL8R2, suggests that IL-8 acts preferentially through IL-8R1. Because elastase release is induced through both receptors and can be precisely quantified, we used this assay to test for agonistic activities of the antibodies. As shown in Table  1 Effects on the Respiratory Burst. The production of superoxide ensues from the stimulus-dependent assembly and activation of the NADPH oxidase. By monitoring the superoxide dismutase-inhibitable reduction of cytochrome c we found a concentration-dependent activation by IL-8 with a maximum at 25-50 nM, but no response to stimulation with either GROa (Fig. 3a) or NAP-2 (data not shown) at concentrations up to 1000 nM. The effect of IL-8 was rapid and transient, and superoxide production leveled off after 20-30 sec (Fig. 3c) . The maximum rate observed was consistent with previous results (13) . The difference in efficacy between IL-8 and the other CXC chemokines was not modified by pretreatment of the cells with cytochalasin B which enhances receptordependent responsiveness (14) . These results suggested that the respiratory burst could only be elicited through IL-8R1. As shown in Fig. 3 , this hypothesis was fully confirmed using the receptor antibodies: The IL-8-dependent superoxide production was inhibited in a concentration dependent manner by anti-IL8R1, but was not affected by anti-IL8R2.
Effects on PLD. Activation of PLD is observed when neutrophils are stimulated with fMet-Leu-Phe and some other chemoattractants (15) . Phosphatidic acid, the product obtained, has been shown to elicit the respiratory burst (16) , and therefore PLD activation is considered a potential intermediate step in the activation of the NADPH oxidase. Using Anti-IL8R1 Anti-IL8R1/1L8R2 [Ca2+]1 changes, expression of complement receptor 1 and 3, the release of granule enzymes, and the respiratory burst (14, 18) . On the basis of such activities, we originally characterized IL-8 as a potential chemotactic agonist (8, 13) and subsequently attributed similar properties to NAP-2 (11), GROa (19) , GRO,B, and GROT (12) , and ENA-78 (20) . The respiratory burst response to the IL-8-related chemokines, however, was very weak and detectable only thanks to a highly sensitive chemiluminescence assay for H202 (21) . The present demonstration that IL-8R2 does not signal for the respiratory burst suggests that the activities reported previously were due to interaction with IL-8R1.
Receptor-specific monoclonal antibodies have been used in other laboratories to assess possible differences in the ability of IL-8R1 and IL-8R2 to elicit chemotaxis. Chuntharapai and Kim, (22) suggested that IL-8R2 is primarily involved in neutrophil recruitment, while IL-8R1 may have a more active role at the site of inflammation. Hammond et al. (23) , however, came to the opposite conclusion, suggesting that chemotaxis to IL-8 depends predominantly on IL-8R1. We have found it difficult to consistently inhibit in vitro chemotaxis with either one of the antibodies selected for this study (S.Q. and S.A.J., unpublished observation). Since migration depends on multiple responses, such as adherence, cytoskeletal changes, enzyme release, etc., and is not assessed in real time, we consider chemotaxis unsuitable for the study of receptor usage by means of competing antibodies. Earlier reports demonstrating that IL-8 and related CXC chemokines attract neutrophils in vitro and in vivo (1) , and the observation that Jurkat cells expressing either IL-8R1 or IL-8R2 show identical in vitro chemotaxis in response to IL-8, provide unquestionable evidence that both IL-8 receptors signal for migration (4) .
Our L'Heureux et al. (24) found no differences in the [Ca2+], changes and the patterns of phosphorylation after stimulation with IL-8, GROa, or NAP-2, and we obtained the same degree of activation of the p42/p44 mitogen-activating protein kinase in IL-8-stimulated Jurkat transfectants expressing either IL-8R1 or IL-8R2 (5).
It is conceivable that IL-8R1 and IL-8R2 activate different signaling pathways, possibly through the coupling to G proteins with distinct a subunits as shown by Gierschik et al. (25) for the fMet-Leu-Phe receptor. Several studies have shown that single neutrophil functions such as the shape change (which is a correlate of motion), enzyme release, and activation of the NADPH oxidase are regulated at different levels of the signal transduction sequence (26) . Inhibitors of protein kinase C, for instance, block superoxide production but not granule exocytosis (27) . Protein kinase C is activated by diacylglycerol which is produced by phosphatidylinositol-or phosphatidylcholinespecific phospholipases C or, via phosphatidic acid, by PLD (15, 28) . It has been reported that the phosphatidylinositolspecific phospholipase C is activated by (29) , but little is known regarding the activation of the other phospholipase C isoforms (30) . In addition to diacylglycerol, the immediate product of PLD, phosphatidic acid, is considered an activator of NADPH oxidase (16, 31) . From these considerations it is plausible that PLD and NADPH oxidase activation are linked and, therefore, affected to a similar extent by the antibodies that block IL-8R1.
The present study documents that the two IL-8 receptors elicit distinct patterns of responses in neutrophils, and suggests that IL-8, which is the only CXC chemokine with high affinity to IL-8R1, may have functions that cannot be fulfilled by its analogs, the GRO proteins, NAP-2, and ENA-78. Since all CXC chemokines, however, are fully capable of eliciting chemotaxis and neutrophil accumulation in the tissues (1), the 
